OncoRes Medical
Perth, Australia· Est.
Real‑time OCT‑elastography platform for intra‑operative tumor margin detection.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Real‑time OCT‑elastography platform for intra‑operative tumor margin detection.
Oncology
Technology Platform
Quantitative Micro‑Elastography (QME) combines high‑resolution optical coherence tomography with micro‑elastography to produce real‑time, histology‑grade maps of tissue stiffness and micro‑structure during surgery.
Opportunities
Rapid adoption in surgical oncology could drive early revenue, and the platform’s versatility may enable expansion into other surgical specialties and integration with AI‑based image analysis.
Risk Factors
Regulatory approval timelines, demonstration of clinical benefit over existing margin assessment methods, and competition from other intra‑operative imaging technologies.
Competitive Landscape
Competitors include pure OCT systems, Raman spectroscopy devices, and elastography platforms; OncoRes differentiates by fusing OCT with micro‑elastography to deliver combined structural and mechanical information in a single, real‑time image.